Nisa Investment Advisors
ECYT

Nisa Investment Advisors’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Nisa Investment Advisors’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-370
Closed -$7K – 2003
2018
Q3 		$7K Buy
+370
New +$6.35K ﹤0.01% 1829

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Nisa Investment Advisors's ECYT Position: Q4 2018 in Review

Nisa Investment Advisors sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 370 shares — an estimated $7K sold.

Nisa Investment Advisors first reported a position in ECYT in Q3 2018 and held it in 1 quarter. The position peaked at $7K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • Nisa Investment Advisors reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Nisa Investment Advisors sold 370 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $7K.
  • Nisa Investment Advisors first reported a position in Endocyte, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • Nisa Investment Advisors's Endocyte, Inc. Common Stock position peaked at $7K in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Nisa Investment Advisors's 13F filing for Q4 2018, filed 17 Jan 2019.